CALC: CalciMedica, Inc. Stock

by  •  • Comments Off on CALC: CalciMedica, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 64.44
Enterprise Value ($M) 58.91
Book Value ($M) 8.16
Book Value / Share 0.76
Price / Book 7.90
NCAV ($M) 7.58
NCAV / Share 0.71
Price / NCAV 8.50

Profitability (mra)
Return on Invested Capital (ROIC) -4.21
Return on Assets (ROA) -0.99
Return on Equity (ROE) -1.56

Liquidity (mrq)
Quick Ratio 2.88
Current Ratio 2.88

Balance Sheet (mrq) ($M)
Current Assets 11.61
Assets 12.19
Liabilities 4.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -38.08
Net Income -34.36

Cash Flow Statement (mra) ($M)
Cash From Operations -25.73
Cash from Investing 8.88
Cash from Financing 20.90

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-08 13G/A Soleus Capital Master Fund, L.P. 9.99 40.96
02-08 13D/A Valence Investments SPV VI, LLC 11.00 20.06
02-07 13G/A BML Investment Partners, L.P. 2.10
02-05 13D/A Orbimed Advisors Llc 2.90 0.00
02-01 13G Aisling Capital V, LP 5.10
02-01 13G Flynn James E 9.99 844.01
01-31 13G Stonepine Capital Management, LLC 9.70

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (AMENDMENT NO. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ T
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 418 6,512 6.42
2024-05-02 2,391 25,696 9.30
2024-05-01 3,955 2,183 181.17
2024-04-30 5,326 2,753 193.46
2024-04-29 1,250 7,344 17.02

(click for more detail)

Similar Companies
BPTH – Bio-Path Holdings, Inc. BTAI – BioXcel Therapeutics, Inc.
BYSI – BeyondSpring Inc. CAPR – Capricor Therapeutics, Inc.
CASI – CASI Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io